MRI-based IMPT planning for prostate cancer
For accurate dose calculations, Proton therapy planning requires the conversion of the computed tomography (CT) data from Hounsfield units (HU) to relative proton stopping power (RSP) according to an appropriate mapping [1]. That conversion prevents using other imaging modalities such as cone-beam CT, magnetic resonance imaging (MR), positron emission tomography, etc. for proton dose calculations.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Nicolas Depauw, Jani Keyril äinen, Sami Suilamo, Lizette Warner, Karl Bzdusek, Christine Olsen, Hanne Kooy Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | MRI Scan | PET Scan | Prostate Cancer | Proton Therapy | Radiology